Dental implant treatment in patients with cancer on high-dose antiresorptive medication: A prospective feasibility study with 2 years follow-up.

Camilla OttesenS W M AndersenSimon Storgård JensenT KofodKlaus Gotfredsen

Published in: Clinical oral implants research (2023)

Dental implant treatment, with high survival and success rate and increased post-treatment OHLQoL, is feasible in HDAR patients after 2 years of loading. Caution with general recommendations should be exercised.

Keyphrases

high dose
end stage renal disease
healthcare
ejection fraction
low dose
newly diagnosed
combination therapy
soft tissue
peritoneal dialysis
adverse drug
smoking cessation